Erratum to: Clinical impact of ¹¹C-methionine PET on expected management of patients with brain neoplasm

Erratum to: Eur J Nucl Med Mol Imaging

DOI 10.1007/s00259-009-1302-y

Parts a and b of Fig. 2 were transposed. The correct figure is reproduced here.

Fig. 2

MRI T1-weighted image with contrast media (a) and fluid attenuated inversion recovery (b), and ¹¹C-MET PET (c) images of cerebellar tumor (arrows). The Chief complaint was weak abnormal feeling in the legs for several months. This lesion was found as high intensity area in images of fluid attenuated inversion recovery. However, as this lesion did not enhance and symptom was not progressive, the physician decided to watch the patient for several months without any treatment. However, increased uptake in ¹¹C-MET PET led this patient to biopsy and operation that followed. Finally, this case was diagnosed as diffuse astrocytoma (grade II)